Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect.
暂无分享,去创建一个
M. V. D. van den Brink | B. Kappel | J. Ferrara | S. Burakoff | T. Teshima | O. Alpdogan | M. Brink | S. Muriglan | C. Schmaltz | K. J. Horndasch | Barry J Kappel | Cornelius Schmaltz